Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,228,980
+$261,381 QoQ
Shares Held
107,096
-43.2% QoQ
Ownership
0.368%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#42
of 211 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. ANAB ranks #40 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in ANAB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,228,980 | 107,096 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,967,599 | 125,633 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $10,445,209 | 215,454 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,597,190 | 215,454 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,783,078 | 215,454 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,005,279 | 215,454 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,852,621 | 215,454 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,537,788 | 75,755 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,898,424 | 75,755 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $978,311 | 43,442 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $930,527 | 43,442 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $780,216 | 43,442 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $883,610 | 43,442 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $945,300 | 43,442 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,346,267 | 43,442 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,230,655 | 48,242 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $920,440 | 45,342 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,121,758 | 45,342 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,557,914 | 44,832 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,178,147 | 43,442 | Shares | Sole | 2021-11-12 | |
| 2020-09-30 | $339,322 | 23,005 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||